肺炎链球菌疫苗和经济学研究  

Streptococcus pneumoniae vaccine and economic research

作　　者：刘军[1] 姚开虎 徐保平[1] 申昆玲[1] 杨永弘[1,3] Liu Jun;Yao Kaihu;Xu Baoping;Shen Kunling;Yang Yonghong(China National Clinical Research Center for Respiratory Diseases,Department of Respiratory Medicine,Beijing Children′s Hospital,Capital Medical University,National Center for Children′s Health,Beijing 100045,China;National Center for Children′s Health,Beijing Children′s Hospital,Capital Medical University,Beijing Pediatric Research Institute,National Key Discipline of Pediatrics(Capital Medical University),National Clinical Research Center for Respiratory Diseases,Key Laboratory of Major Diseases in Children,Ministry of Education,Beijing Key Laboratory of Pediatric Respiratory Infectious Diseases,Beijing 100045,China;Department of Respiration,Shenzhen Children′s Hospital,Shenzhen 518000,Guangdong Province,China)

机构地区：[1]国家儿童医学中心,首都医科大学附属北京儿童医院呼吸科,国家呼吸系统疾病临床医学研究中心,北京100045 [2]国家儿童医学中心,首都医科大学附属北京儿童医院,北京市儿科研究所,首都医科大学儿科学国家重点学科,国家呼吸系统疾病临床医学研究中心,教育部儿科重大疾病研究重点实验室,儿童呼吸道感染性疾病研究北京市重点实验室,100045 [3]深圳市儿童医院呼吸科,广东深圳518000

出　　处：《中华实用儿科临床杂志》2020年第7期547-549,共3页Chinese Journal of Applied Clinical Pediatrics

摘　　要：肺炎链球菌性疾病是全球严重的公共卫生问题之一,给全球儿童和成人带来了严重的健康威胁和沉重的经济负担。已在全球证明肺炎链球菌疫苗(PCV)是一种安全有效的干预措施,可预防侵袭性和非侵袭性肺炎链球菌性疾病。在世界范围内使用PCV在挽救生命、避免残疾及成本效益方面均有很大益处,特别是在非洲和亚洲。Pneumococcal diseases are one of the serious global public health problems,which seriously threa-tens the health and brings heavy economic burden to children and adults in the world.Pneumococcal conjugated vaccines(PCVs)have been proved to be a safe and effective intervention to prevent invasive and non-invasive pneumococcal diseases.PCVs are conducive to saving lives,preventing disability and lowering costs in the world,especially in Africa and Asia.

关 键 词：肺炎链球菌结合疫苗 成本效果分析 儿童 

分 类 号：R51[医药卫生—内科学]